The purpose of this study is to find out if it is practical (feasible) to give dose-dense CMF (cyclophosphamide, methotrexate, and fluorouracil) in two standar…

Adenocarcinoma of the BreastBreast CancerTriple Negative Breast Cancer

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07768436

Observational

Accuracy and Effect of Prescribed Generative AI Patient Education Module Within Breast Oncology Care

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for b…

Breast CancerMetastatic Breast CancerCarcinoma of the Breast

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT07512271

Phase 1

SHARON: Study of Metastatic Cancers in Patients Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic…

Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more

~Estimated

~$10 – $8,750

General Oncology, Inc.

NCT04150042